Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $30,483 | 7 | 75.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,020 | 4 | 12.4% |
| Food and Beverage | $3,049 | 40 | 7.6% |
| Travel and Lodging | $1,060 | 5 | 2.6% |
| Consulting Fee | $700.00 | 1 | 1.7% |
| Education | $37.65 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch Health US, LLC | $30,483 | 7 | $0 (2020) |
| Shire North American Group Inc | $5,511 | 11 | $0 (2018) |
| CooperVision Inc. | $1,332 | 9 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $886.86 | 3 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $320.96 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $242.89 | 3 | $0 (2021) |
| Sight Sciences, Inc. | $241.84 | 3 | $0 (2022) |
| Thea Pharma Inc. | $202.19 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $200.83 | 2 | $0 (2024) |
| Alcon Vision LLC | $171.38 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.53 | 2 | Thea Pharma Inc. ($97.82) |
| 2023 | $535.22 | 5 | Horizon Therapeutics plc ($124.99) |
| 2022 | $303.30 | 3 | Sight Sciences, Inc. ($112.20) |
| 2021 | $1,279 | 8 | Kala Pharmaceuticals, Inc. ($886.86) |
| 2020 | $6,529 | 13 | Bausch Health US, LLC ($5,346) |
| 2019 | $25,495 | 9 | Bausch Health US, LLC ($25,137) |
| 2018 | $234.42 | 4 | GENZYME CORPORATION ($109.02) |
| 2017 | $5,779 | 14 | Shire North American Group Inc ($5,486) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: OPTHALMICS | ||||||
| 04/21/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $96.30 | General |
| Category: OPTHALMICS | ||||||
| 04/21/2017 | Shire North American Group Inc | XIIDRA (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: OPTHALMICS | ||||||
| 04/13/2017 | Rapid Pathogen Screening, Inc. | InflammaDry (Device) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Medical Device | ||||||
| 04/07/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,630.00 | General |
| Category: OPTHALMICS | ||||||
| 03/22/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $83.43 | General |
| Category: OPTHALMICS | ||||||
| 03/02/2017 | Shire North American Group Inc | XIIDRA (Drug) | Education | In-kind items and services | $37.65 | General |
| Category: OPTHALMICS | ||||||
| 02/24/2017 | Shire North American Group Inc | XIIDRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: OPTHALMICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY TO EVALUATE THE SAFETY, EFFECTIVENESS AND PRODUCT PERFORMANCE OF THE BIOTRUE ONEDAY FOR ASTIGMATISM SOFT CONTACT LENS WHEN WORN ON A DAILY BASIS | Bausch Health US, LLC | $25,137 | 3 |
| A STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE BIOTRUE ONEDAY FOR ASTIMGMATISM SOFT CONTACT LEN WHEN WORN ON A DAILY BASIS | Bausch Health US, LLC | $5,346 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 344 | 372 | $131,356 | $22,279 |
| 2022 | 8 | 324 | 351 | $107,938 | $19,744 |
| 2021 | 7 | 342 | 377 | $109,345 | $20,377 |
| 2020 | 5 | 263 | 286 | $111,875 | $20,768 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 232 | 240 | $101,554 | $16,966 | 16.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 42 | 59 | $17,442 | $3,064 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $4,230 | $973.30 | 23.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 14 | $2,840 | $467.21 | 16.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 21 | 22 | $2,510 | $411.98 | 16.4% |
| 92134 | Imaging of retina | Office | 2023 | 19 | 19 | $2,780 | $397.49 | 14.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 118 | 118 | $49,238 | $9,136 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 113 | $31,485 | $5,669 | 18.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 34 | $8,160 | $1,369 | 16.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 16 | 19 | $5,546 | $1,198 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $4,364 | $883.71 | 20.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 19 | 19 | $4,330 | $669.89 | 15.5% |
| 92134 | Imaging of retina | Office | 2022 | 21 | 25 | $3,455 | $595.91 | 17.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 11 | 11 | $1,360 | $223.01 | 16.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 184 | $51,520 | $11,383 | 22.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 54 | 55 | $25,850 | $3,534 | 13.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 47 | $11,280 | $1,897 | 16.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $9,200 | $1,451 | 15.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 17 | 17 | $3,995 | $794.40 | 19.9% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 20 | 24 | $3,720 | $676.83 | 18.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 27 | 27 | $3,780 | $640.68 | 16.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 166 | 177 | $79,650 | $14,699 | 18.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 38 | 50 | $15,750 | $2,911 | 18.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 17 | 17 | $9,095 | $1,722 | 18.9% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 18 | 18 | $4,140 | $762.71 | 18.4% |
About Dr. Michael Depaolis, O.D
Dr. Michael Depaolis, O.D is a Optometrist healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720084346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Depaolis, O.D has received a total of $40,349 in payments from pharmaceutical and medical device companies, with $193.53 received in 2024. These payments were reported across 58 transactions from 20 companies. The most common payment nature is "" ($30,483).
As a Medicare-enrolled provider, Depaolis has provided services to 1,273 Medicare beneficiaries, totaling 1,386 services with total Medicare billing of $83,168. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Corneal and Contact Management
- Location Rochester, NY
- Active Since 06/28/2005
- Last Updated 07/05/2023
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1720084346
Products in Payments
- BIOTRUE ONEDAY FOR ASTIGMATISM (Device) $30,483
- XIIDRA (Drug) $5,754
- MiSight Contact Lens (Device) $1,109
- EYSUVIS (Drug) $784.25
- Cequa (Drug) $217.12
- IYUZEH (Drug) $202.19
- INFUSE (Device) $200.83
- Clariti Contact Lens (Device) $131.19
- TearCare SmartLid (Device) $129.64
- TEPEZZA (Drug) $124.99
- AcrySof IQ PanOptix UV IOL (Device) $112.77
- OMNI(R) SURGICAL SYSTEM (US) (Device) $112.20
- CEREZYME (Drug) $109.02
- CEQUA (Drug) $103.84
- INVELTYS (Drug) $102.61
- Multiple Brands Contact Lens (Device) $91.94
- Tecnis Symfony IOL (Device) $87.00
- VYZULTA (Drug) $77.96
- PROLENSA (Drug) $70.86
- ILUX (Device) $33.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Rochester
Dr. Vadim Guy, O.d, O.D
Optometrist — Payments: $34,690
Dr. Lisa Chute, Od, OD
Optometrist — Payments: $8,779
Dr. Lorne Gottesman, O.d, O.D
Optometrist — Payments: $6,240
Cathy Wing Man Yuen, O.d, O.D
Optometrist — Payments: $4,871
Dr. Cary Kazdan, O.d, O.D
Optometrist — Payments: $4,701
Paul Hanlon, Od, OD
Optometrist — Payments: $4,532